Is the gemcitabin-cisplatin combination the optimal induction chemotherapy for non-Asian patients with nasopharyngeal carcinoma (NPC)? Insights from a cohort in northeastern Morocco.

Ecancermedicalscience · 2025 · PMC11959120 · PMID 40177149

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In a Chinese phase III trial published in the New England Journal of Medicine, Zhang et al [ 13 ] retrospectively reported that the GP regimen had a positive effect on OS and showed a trend toward better DFS.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.